IRIS Accounts Production v24.1.0.578 07205080 Board of Directors 1.4.23 31.3.24 31.3.24 false true false false false true false A Ordinary shares 1.00000 B Ordinary shares 1.00000 C Ordinary Share 1.00000 D Ordinary Share 1.00000 733 1452 4367 22431 4671 21712 1037 733 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh072050802023-03-31072050802024-03-31072050802023-04-012024-03-31072050802022-03-31072050802022-04-012023-03-31072050802023-03-3107205080ns15:EnglandWales2023-04-012024-03-3107205080ns14:PoundSterling2023-04-012024-03-3107205080ns10:Director12023-04-012024-03-3107205080ns10:PrivateLimitedCompanyLtd2023-04-012024-03-3107205080ns10:SmallEntities2023-04-012024-03-3107205080ns10:AuditExempt-NoAccountantsReport2023-04-012024-03-3107205080ns10:SmallCompaniesRegimeForDirectorsReport2023-04-012024-03-3107205080ns10:SmallCompaniesRegimeForAccounts2023-04-012024-03-3107205080ns10:FullAccounts2023-04-012024-03-310720508012023-04-012024-03-3107205080ns10:OrdinaryShareClass12023-04-012024-03-3107205080ns10:OrdinaryShareClass22023-04-012024-03-3107205080ns10:OrdinaryShareClass32023-04-012024-03-3107205080ns10:OrdinaryShareClass42023-04-012024-03-310720508042ns10:Director22023-03-310720508042ns10:Director22022-03-310720508042ns10:Director22023-04-012024-03-310720508042ns10:Director22022-04-012023-03-310720508042ns10:Director22024-03-310720508042ns10:Director22023-03-3107205080ns5:CurrentFinancialInstruments2024-03-3107205080ns5:CurrentFinancialInstruments2023-03-3107205080ns5:ShareCapital2024-03-3107205080ns5:ShareCapital2023-03-3107205080ns5:SharePremium2024-03-3107205080ns5:SharePremium2023-03-3107205080ns5:RetainedEarningsAccumulatedLosses2024-03-3107205080ns5:RetainedEarningsAccumulatedLosses2023-03-3107205080ns10:RegisteredOffice2023-04-012024-03-3107205080ns5:NetGoodwill2023-04-012024-03-3107205080ns5:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3107205080ns5:FurnitureFittings2023-04-012024-03-3107205080ns5:MotorVehicles2023-04-012024-03-3107205080ns5:NetGoodwill2023-03-3107205080ns5:NetGoodwill2024-03-3107205080ns5:NetGoodwill2023-03-3107205080ns5:FurnitureFittings2023-03-3107205080ns5:MotorVehicles2023-03-3107205080ns5:FurnitureFittings2024-03-3107205080ns5:MotorVehicles2024-03-3107205080ns5:FurnitureFittings2023-03-3107205080ns5:MotorVehicles2023-03-3107205080ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-03-3107205080ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-03-3107205080ns10:OrdinaryShareClass12024-03-3107205080ns10:OrdinaryShareClass22024-03-3107205080ns10:OrdinaryShareClass32024-03-3107205080ns10:OrdinaryShareClass42024-03-3107205080ns10:Director22023-04-012024-03-31072050801ns10:Director12023-03-31072050801ns10:Director12022-03-31072050801ns10:Director12023-04-012024-03-31072050801ns10:Director12022-04-012023-03-31072050801ns10:Director12024-03-31072050801ns10:Director12023-03-31
REGISTERED NUMBER: 07205080 (England and Wales)















Unaudited Financial Statements for the Year Ended 31st March 2024

for

Herts & Essex Urology Ltd

Herts & Essex Urology Ltd (Registered number: 07205080)






Contents of the Financial Statements
for the Year Ended 31st March 2024




Page

Balance Sheet 1

Notes to the Financial Statements 3


Herts & Essex Urology Ltd (Registered number: 07205080)

Balance Sheet
31st March 2024

31.3.24 31.3.23
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 - -
Tangible assets 5 28,297 37,243
28,297 37,243

CURRENT ASSETS
Debtors 6 21,746 8,201
Cash at bank 354,545 569,520
376,291 577,721
CREDITORS
Amounts falling due within one year 7 3,391 20,828
NET CURRENT ASSETS 372,900 556,893
TOTAL ASSETS LESS CURRENT
LIABILITIES

401,197

594,136

PROVISIONS FOR LIABILITIES 5,376 6,214
NET ASSETS 395,821 587,922

CAPITAL AND RESERVES
Called up share capital 8 102 102
Share premium 160 160
Retained earnings 395,559 587,660
SHAREHOLDERS' FUNDS 395,821 587,922

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31st March 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31st March 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Herts & Essex Urology Ltd (Registered number: 07205080)

Balance Sheet - continued
31st March 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 13th August 2024 and were signed on its behalf by:





Dr B S Potluri - Director


Herts & Essex Urology Ltd (Registered number: 07205080)

Notes to the Financial Statements
for the Year Ended 31st March 2024

1. COMPANY INFORMATION

Herts & Essex Urology Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 07205080

Registered office: The Lexicon
Mount Street
Manchester
M2 5NT

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Revenue from the provision of professional services is recognised on delivery of the service.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2011, has been amortised over its estimated useful life of ten years. The goodwill has been written down to nil in these financial statements being the end of its useful life.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 25% on cost
Motor vehicles - 20% on reducing balance

Tangible fixed assets are included at cost less depreciation and impairment. Depreciation has been computed to write off the cost of tangible fixed assets over their expected useful life as follows:

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to the profit or loss.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


Herts & Essex Urology Ltd (Registered number: 07205080)

Notes to the Financial Statements - continued
for the Year Ended 31st March 2024

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2023 - 2 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1st April 2023
and 31st March 2024 926,180
AMORTISATION
At 1st April 2023
and 31st March 2024 926,180
NET BOOK VALUE
At 31st March 2024 -
At 31st March 2023 -

5. TANGIBLE FIXED ASSETS
Fixtures
and Motor
fittings vehicles Totals
£    £    £   
COST
At 1st April 2023
and 31st March 2024 15,092 50,840 65,932
DEPRECIATION
At 1st April 2023 10,387 18,302 28,689
Charge for year 2,438 6,508 8,946
At 31st March 2024 12,825 24,810 37,635
NET BOOK VALUE
At 31st March 2024 2,267 26,030 28,297
At 31st March 2023 4,705 32,538 37,243

Herts & Essex Urology Ltd (Registered number: 07205080)

Notes to the Financial Statements - continued
for the Year Ended 31st March 2024

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.24 31.3.23
£    £   
Trade debtors 3,659 8,201
Tax 18,087 -
21,746 8,201

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.24 31.3.23
£    £   
Tax - 18,087
Social security and other taxes 2,354 2,007
Directors' current accounts 1,038 733
Accrued expenses (1 ) 1
3,391 20,828

8. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.3.24 31.3.23
value: £    £   
60 A Ordinary shares £1 60 60
40 B Ordinary shares £1 40 40
1 C Ordinary Share £1 1 1
1 D Ordinary Share £1 1 1
102 102

The Ordinary A shares confer on the holders the right to vote upon any resolution proposed at any general meeting of the company.

The Ordinary B shares, Ordinary C shares and Ordinary D shares do not confer on the holders the right to vote upon any resolution proposed at any general meeting of the company.

The A, B, C and D shares rank pari passu in respect of dividend and capital distribution rights.

9. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 31st March 2024 and 31st March 2023:

31.3.24 31.3.23
£    £   
Dr B S Potluri and Mrs S D Potluri
Balance outstanding at start of year (733 ) (1,452 )
Amounts advanced 4,367 22,431
Amounts repaid (4,671 ) (21,712 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (1,037 ) (733 )

The loan is payable on demand and no interest is charged during the year.

10. CONTROL

The ultimate controlling party is Dr B S Potluri by virtue of holding 100% of the voting share capital.